Biblio

Export 68 results:
[ Author(Asc)] Keyword Title Type Year
Filters: First Letter Of Last Name is N  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
N
A. Nørgaard, Jensen-Dahm, C., Gasse, C., Hansen, H. Vibe, and Waldemar, G., “Time trends in antipsychotic drug use in patients with dementia: a nationwide study.”, J Alzheimers Dis, vol. 49, no. 1, pp. 211-20, 2016.
A. Nørgaard, Jensen-Dahm, C., Gasse, C., Hansen, E. Steno, and Waldemar, G., “Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.”, J Alzheimers Dis, vol. 56, no. 2, pp. 707-716, 2017.
K. Nunez, Kay, J., Krotow, A., Tong, M., Agarwal, A. R., Cadenas, E., and de la Monte, S. M., “Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 151-63, 2016.
K. N. H. Nudelman, Lin, J., Lane, K. A., Nho, K., Kim, S., Faber, K. M., Risacher, S. L., Foroud, T. M., Gao, S., Davis, J. W., Weiner, M. W., and Saykin, A. J., “Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort.”, J Alzheimers Dis, vol. 71, no. 1, pp. 33-43, 2019.
G. Novak, Fox, N., Clegg, S., Nielsen, C., Einstein, S., Lu, Y., Tudor, I. Cristina, Gregg, K., Di, J., Collins, P., Wyman, B. T., Yuen, E., Grundman, M., H Brashear, R., and Liu, E., “Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1123-34, 2016.
P. Novak, Cehlar, O., Skrabana, R., and Novak, M., “Tau Conformation as a Target for Disease-Modifying Therapy: The Role of Truncation.”, J Alzheimers Dis, vol. 64, no. s1, pp. S535-S546, 2018.
B. Nouriziabari, Sarkar, S., Tanninen, S. E., Dayton, R. D., Klein, R. L., and Takehara-Nishiuchi, K., “Aberrant Cortical Event-Related Potentials During Associative Learning in Rat Models for Presymptomatic Stages of Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 2, pp. 725-740, 2018.
J. M. Nolan, Power, R., Howard, A. N., Bergin, P., Roche, W., Prado-Cabrero, A., Pope, G., Cooke, J., Power, T., and Mulcahy, R., “Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 90, no. 1, pp. 233-249, 2022.
J. M. Nolan, Mulcahy, R., Power, R., Moran, R., and Howard, A. N., “Nutritional Intervention to Prevent Alzheimer's Disease: Potential Benefits of Xanthophyll Carotenoids and Omega-3 Fatty Acids Combined.”, J Alzheimers Dis, vol. 64, no. 2, pp. 367-378, 2018.
Y. Noh, Seo, S. Won, Jeon, S., Lee, J. Min, Kim, J. Seung, Lee, J. - H., Kim, J. - H., Kim, G. Ha, Ye, B. Seok, Cho, H., Kim, H. Jin, Yoon, C. W., Choe, Y. Seong, Lee, K. - H., Weiner, M. W., and Na, D. L., “The Role of Cerebrovascular Disease in Amyloid Deposition.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1015-1026, 2016.
M. Levy Nogueira, Samri, D., Epelbaum, S., Lista, S., Suppa, P., Spies, L., Hampel, H., Dubois, B., and Teichmann, M., “Alzheimer's Disease Diagnosis Relies on a Twofold Clinical-Biological Algorithm: Three Memory Clinic Case Reports.”, J Alzheimers Dis, vol. 60, no. 2, pp. 577-583, 2017.
M. Noguchi-Shinohara, Komatsu, J., Samuraki, M., Matsunari, I., Ikeda, T., Sakai, K., Hamaguchi, T., Ono, K., Nakamura, H., and Yamada, M., “Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 905-913, 2017.
M. Noguchi-Shinohara, Abe, C., Yuki-Nozaki, S., Dohmoto, C., Mori, A., Hayashi, K., Shibata, S., Ikeda, Y., Sakai, K., Iwasa, K., Yokogawa, M., Ishimiya, M., Nakamura, H., Yokoji, H., Komai, K., Nakamura, H., and Yamada, M., “Higher Blood Vitamin C Levels are Associated with Reduction of Apolipoprotein E E4-related Risks of Cognitive Decline in Women: The Nakajima Study.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1289-1297, 2018.
J. M. Noble, Schupf, N., Manly, J. J., Andrews, H., Tang, M. - X., and Mayeux, R., “Secular Trends in the Incidence of Dementia in a Multi-Ethnic Community.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1065-1075, 2017.
A. Niwa, Ii, Y., Shindo, A., Matsuo, K., Ishikawa, H., Taniguchi, A., Takase, S., Maeda, M., Sakuma, H., Akatsu, H., Hashizume, Y., and Tomimoto, H., “Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and Histopathology.”, J Alzheimers Dis, vol. 59, no. 3, pp. 951-959, 2017.
J. Niu, Iqbal, K., Liu, F., and Hu, W., “Rats Display Sexual Dimorphism in Phosphorylation of Brain Tau with Age.”, J Alzheimers Dis, vol. 82, no. 2, pp. 855-869, 2021.
J. Nishihira, Tokashiki, T., Higashiuesato, Y., Willcox, D. Craig, Mattek, N., Shinto, L., Ohya, Y., and Dodge, H. H., “Associations between Serum Omega-3 Fatty Acid Levels and Cognitive Functions among Community-Dwelling Octogenarians in Okinawa, Japan: The KOCOA Study.”, J Alzheimers Dis, vol. 51, no. 3, pp. 857-66, 2016.
R. M. Nisbet and Götz, J., “Amyloid-β and Tau in Alzheimer's Disease: Novel Pathomechanisms and Non-Pharmacological Treatment Strategies.”, J Alzheimers Dis, vol. 64, no. s1, pp. S517-S527, 2018.
E. D. Nilsson, Melander, O., Elmståhl, S., Lethagen, E., Minthon, L., Pihlsgård, M., and Nägga, K., “Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1047-53, 2016.
A. N. Nilson, English, K. C., Gerson, J. E., T Whittle, B., C Crain, N., Xue, J., Sengupta, U., Castillo-Carranza, D. L., Zhang, W., Gupta, P., and Kayed, R., “Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1083-1099, 2017.
T. Nikolai, Stepankova, H., Kopecek, M., Sulc, Z., Vyhnálek, M., and Bezdicek, O., “The Uniform Data Set, Czech Version: Normative Data in Older Adults from an International Perspective.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1233-1240, 2018.
E. Nikitidou, Khoonsari, P. Emami, Shevchenko, G., Ingelsson, M., Kultima, K., and Erlandsson, A., “Increased Release of Apolipoprotein E in Extracellular Vesicles Following Amyloid-β Protofibril Exposure of Neuroglial Co-Cultures.”, J Alzheimers Dis, vol. 60, no. 1, pp. 305-321, 2017.
S. Hani Mouss Nik, Porter, T., Newman, M., Bartlett, B., Khan, I., Sabale, M., Eccles, M., Woodfield, A., Groth, D., Doré, V., Villemagne, V. L., Masters, C. L., Martins, R. N., Laws, S. M., Lardelli, M., and Verdile, G., “Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer's Disease and Neurodegeneration.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1479-1489, 2021.
E. Niemantsverdriet, Feyen, B. F. E., Le Bastard, N., Martin, J. - J., Goeman, J., De Deyn, P. Paul, Bjerke, M., and Engelborghs, S., “Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort.”, J Alzheimers Dis, vol. 63, no. 1, pp. 373-381, 2018.
E. Niemantsverdriet, Goossens, J., Struyfs, H., Martin, J. - J., Goeman, J., De Deyn, P. Paul, Vanderstichele, H., and Engelborghs, S., “Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 97-106, 2016.

Pages